Fayetteville, Arkansas

Fayetteville, Arkansas 72703

0 studies enrolling now · 2 studies all time

What they study most

Alopecia Areata, Diabetic Macular Edema (DME)

Studies at this site

• A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME — Running, not enrolling
• A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA) — Running, not enrolling